Trust Size
$16M
Peak Price
$428.40
Current Price
$1.00
Return
+10.6%
Price Journey
What Happened
Co-Diagnostics develops molecular diagnostics products, including PCR-based tests for infectious diseases, using its proprietary CoPrimer technology platform.
Co-Diagnostics gained prominence during the COVID-19 pandemic for its PCR testing technology. The company went public and has been developing non-COVID diagnostic products using its CoPrimer platform, which offers improved accuracy over standard PCR. However, as pandemic testing demand waned, revenue declined sharply, leading to going concern warnings.
Timeline
2020-10-13
S-1 Registration Filed
SEC Filing Details
CIK Number
1759186
Total SEC Filings
303
State of Incorporation
DE
Last Filing Date
2026-03-19
Business Location
Miami Beach, FL
Trust/Asset Size
$16M
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
📄 SEC Filings
View all EDGAR filings for Coeptis Therapeutics Holdings